Bone Biologics Ownership 2024 | Who Owns Bone Biologics Now?

OverviewFinancials Chart

Institutional Ownership

0.06%

Insider Ownership

6.07%

Retail Ownership

93.87%

Institutional Holders

1.00

Bone Biologics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	5.10%	-	33,707	33,107	5517.83%	41,123	Jun 30, 2024
HRT FINANCIAL LP	2.65%	0.00%	17,519	17,519	100.00%	21,000	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.88%	0.00%	5,789	1,539	36.21%	7,063	Jun 30, 2024
MFA WEALTH ADVISORS, LLC	0.06%	0.00%	403	403	100.00%	492	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	9	9	100.00%	11	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-4	-100.00%	-	Jun 30, 2024
ARMISTICE CAPITAL, LLC	-	-	-	-37,000	-100.00%	-	Jun 30, 2024

Bone Biologics's largest institutional shareholder is UBS GROUP AG, holding 5.10% of the company's total share outstanding, currently valued at $41.12K. The top 10 institutional shareholders own together 8.69% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TOWER RESEARCH CAPITAL LLC (TRC)	0.88%	0.00%	5,789	1,539	36.21%	7,063	Jun 30, 2024
HRT FINANCIAL LP	2.65%	0.00%	17,519	17,519	100.00%	21,000	Jun 30, 2024
MFA WEALTH ADVISORS, LLC	0.06%	0.00%	403	403	100.00%	492	Jun 30, 2024
UBS GROUP AG	5.10%	-	33,707	33,107	5517.83%	41,123	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	9	9	100.00%	11	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-4	-100.00%	-	Jun 30, 2024
ARMISTICE CAPITAL, LLC	-	-	-	-37,000	-100.00%	-	Jun 30, 2024

The largest Bone Biologics shareholder by % of total assets is TOWER RESEARCH CAPITAL LLC (TRC). The company owns 5.79K shares of Bone Biologics (BBLG), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	5.10%	-	33,707	33,107	5517.83%	41,123	Jun 30, 2024
HRT FINANCIAL LP	2.65%	0.00%	17,519	17,519	100.00%	21,000	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.88%	0.00%	5,789	1,539	36.21%	7,063	Jun 30, 2024
MFA WEALTH ADVISORS, LLC	0.06%	0.00%	403	403	100.00%	492	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	9	9	100.00%	11	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-4	-100.00%	-	Jun 30, 2024
ARMISTICE CAPITAL, LLC	-	-	-	-37,000	-100.00%	-	Jun 30, 2024

As of Jun 30 2024, Bone Biologics's largest institutional buyer is UBS GROUP AG. The company purchased 33.11K stocks of BBLG, valued at $41.12K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARMISTICE CAPITAL, LLC	-	-	-	-37,000	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-4	-100.00%	-	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	9	9	100.00%	11	Jun 30, 2024
MFA WEALTH ADVISORS, LLC	0.06%	0.00%	403	403	100.00%	492	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.88%	0.00%	5,789	1,539	36.21%	7,063	Jun 30, 2024
HRT FINANCIAL LP	2.65%	0.00%	17,519	17,519	100.00%	21,000	Jun 30, 2024
UBS GROUP AG	5.10%	-	33,707	33,107	5517.83%	41,123	Jun 30, 2024

As of Jun 30 2024, Bone Biologics's biggest institutional seller is ARMISTICE CAPITAL, LLC. The company sold -37.00K shares of BBLG, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
HRT FINANCIAL LP	2.65%	0.00%	17,519	17,519	100.00%	21,000	Jun 30, 2024
MFA WEALTH ADVISORS, LLC	0.06%	0.00%	403	403	100.00%	492	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	9	9	100.00%	11	Jun 30, 2024

Bone Biologics's largest new institutional shareholder by number of shares is HRT FINANCIAL LP, purchased 17.52K shares, valued at $21.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARMISTICE CAPITAL, LLC	-	-	-	-37,000	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-4	-100.00%	-	Jun 30, 2024

Bone Biologics's largest sold out institutional shareholder by shares sold is ARMISTICE CAPITAL, LLC, sold -37.00K shares, valued at -, as of undefined.

Bone Biologics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	33,461	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	15,816	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	5,900	-	-	Feb 29, 2024

Bone Biologics's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 33.46K shares, compromising 0.00% of its total assets.

Bone Biologics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	1	-75.00%
31 Mar, 24	4	100.00%
31 Dec, 23	2	-75.00%
30 Sep, 23	8	14.29%
30 Jun, 23	7	-12.50%
31 Mar, 23	8	-33.33%
31 Dec, 22	12	500.00%
30 Sep, 22	2	-33.33%
30 Jun, 22	3	-
31 Mar, 22	3	-

As of 30 Jun 24, 1 institutions are holding Bone Biologics's shares, representing a decrease of -75.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	403	-99.04%
31 Mar, 24	41,854	3305.53%
31 Dec, 23	1,229	-99.63%
30 Sep, 23	330,640	-18.32%
30 Jun, 23	404,792	-83.83%
31 Mar, 23	2,502,773	10.56%
31 Dec, 22	2,263,720	5376.12%
30 Sep, 22	41,338	-12.60%
30 Jun, 22	47,299	-17.98%
31 Mar, 22	57,666	-

Bone Biologics (BBLG) has 403.00 shares outstanding as of 30 Jun 24, down -99.04% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	0.06%	0.15%
31 Mar, 24	6.33%	11968.43%
31 Dec, 23	0.23%	0.21%
30 Sep, 23	10.55%	6.32%
30 Jun, 23	12.91%	141.37%
31 Mar, 23	3.02%	40.44%
31 Dec, 22	2.73%	109741.88%
30 Sep, 22	0.05%	1530.65%
30 Jun, 22	0.06%	1178.45%
31 Mar, 22	0.07%	-

As of 30 Jun 24, Bone Biologics is held by 0.06% institutional shareholders, representing a 0.15% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	1	-66.67%
31 Mar, 24	3	-
31 Dec, 23	-	-100.00%
30 Sep, 23	6	200.00%
30 Jun, 23	2	-50.00%
31 Mar, 23	4	-66.67%
31 Dec, 22	12	1100.00%
30 Sep, 22	1	-50.00%
30 Jun, 22	2	-33.33%
31 Mar, 22	3	-

1 institutional shareholders have increased their position in BBLG stock as of 30 Jun 24 compared to 3 in the previous quarter (a -66.67% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	-	-
31 Mar, 24	-	-100.00%
31 Dec, 23	2	-
30 Sep, 23	2	-60.00%
30 Jun, 23	5	150.00%
31 Mar, 23	2	-
31 Dec, 22	-	-
30 Sep, 22	-	-
30 Jun, 22	-	-
31 Mar, 22	-	-

- institutional shareholders have reduced their position in BBLG stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	1	-75.00%	403	-99.04%	0.06%	0.15%	1	-66.67%	-	-
31 Mar, 24	4	100.00%	41,854	3305.53%	6.33%	11968.43%	3	-	-	-100.00%
31 Dec, 23	2	-75.00%	1,229	-99.63%	0.23%	0.21%	-	-100.00%	2	-
30 Sep, 23	8	14.29%	330,640	-18.32%	10.55%	6.32%	6	200.00%	2	-60.00%
30 Jun, 23	7	-12.50%	404,792	-83.83%	12.91%	141.37%	2	-50.00%	5	150.00%
31 Mar, 23	8	-33.33%	2,502,773	10.56%	3.02%	40.44%	4	-66.67%	2	-
31 Dec, 22	12	500.00%	2,263,720	5376.12%	2.73%	109741.88%	12	1100.00%	-	-
30 Sep, 22	2	-33.33%	41,338	-12.60%	0.05%	1530.65%	1	-50.00%	-	-
30 Jun, 22	3	-	47,299	-17.98%	0.06%	1178.45%	2	-33.33%	-	-
31 Mar, 22	3	-	57,666	-	0.07%	-	3	-	-	-

Bone Biologics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Sep 14, 2023	Walsh Deina H	officer	Chief Financial Officer	P-Purchase	Buy	8,000	$0.64	$5.12K	15,000
Sep 12, 2023	Frelick Jeff	officer	Chief Executive Officer	P-Purchase	Buy	9,500	$0.69	$6.53K	17,204
Sep 07, 2023	Walsh Deina H	officer	Chief Financial Officer	P-Purchase	Buy	6,700	$0.71	$4.76K	7,000
Sep 07, 2023	Walsh Deina H	officer	Chief Financial Officer	P-Purchase	Buy	300	$0.70	$210.00	300
Sep 05, 2023	Frelick Jeff	officer	Chief Executive Officer	P-Purchase	Buy	7,600	$0.66	$5.02K	7,704

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Sep 14, 2023	Walsh Deina H	officer	Chief Financial Officer	P-Purchase	Buy	8,000	$0.64	$5.12K	15,000
Sep 12, 2023	Frelick Jeff	officer	Chief Executive Officer	P-Purchase	Buy	9,500	$0.69	$6.53K	17,204
Sep 07, 2023	Walsh Deina H	officer	Chief Financial Officer	P-Purchase	Buy	6,700	$0.71	$4.76K	7,000
Sep 07, 2023	Walsh Deina H	officer	Chief Financial Officer	P-Purchase	Buy	300	$0.70	$210.00	300
Sep 05, 2023	Frelick Jeff	officer	Chief Executive Officer	P-Purchase	Buy	7,600	$0.66	$5.02K	7,704

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jan 10, 2024	Gagnon Robert E.	director	-		Sell	-	-	-	-
Mar 29, 2023	Hankey Don	director, 10 percent owner, officer	Chairman of the Board	J-Other	Sell	33,811	$6.30	$213.01K	-
Mar 29, 2023	Hankey Don	director, 10 percent owner, officer	Chairman of the Board	J-Other	Sell	500,137	-	-	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jan 19, 2024	Walsh Deina H	officer	Chief Financial Officer	A-Award	Buy	12,500	$3.61	$45.13K	12,500
Jan 19, 2024	Frelick Jeff	officer	Chief Executive Officer	A-Award	Buy	25,000	$3.61	$90.25K	25,000
Jan 10, 2024	Gagnon Robert E.	director	-	A-Award	Buy	8	$4.68	$37.47	8,015
Jan 10, 2024	Gagnon Robert E.	director	-	A-Award	Buy	9	$4.68	$42.12	9
Jan 10, 2024	Gagnon Robert E.	director	-		Sell	-	-	-	-
Sep 20, 2023	Lucera Erick	director	-	A-Award	Buy	85,763	$0.64	$54.89K	85,763
Sep 20, 2023	Angle Siddhesh Rajendra	director	-	A-Award	Buy	85,763	$0.64	$54.89K	85,763
Sep 20, 2023	Stroever Bruce	director	-	A-Award	Buy	85,763	$0.64	$54.89K	85,763
Sep 14, 2023	Walsh Deina H	officer	Chief Financial Officer	P-Purchase	Buy	8,000	$0.64	$5.12K	15,000
Sep 12, 2023	Frelick Jeff	officer	Chief Executive Officer	P-Purchase	Buy	9,500	$0.69	$6.53K	17,204
Sep 07, 2023	Walsh Deina H	officer	Chief Financial Officer	P-Purchase	Buy	6,700	$0.71	$4.76K	7,000
Sep 07, 2023	Walsh Deina H	officer	Chief Financial Officer	P-Purchase	Buy	300	$0.70	$210.00	300
Sep 05, 2023	Frelick Jeff	officer	Chief Executive Officer	P-Purchase	Buy	7,600	$0.66	$5.02K	7,704
Mar 29, 2023	Hankey Don	director, 10 percent owner, officer	Chairman of the Board	J-Other	Buy	280,764	$6.30	$1.77M	280,764
Mar 29, 2023	Hankey Don	director, 10 percent owner, officer	Chairman of the Board	J-Other	Buy	99,148	$6.30	$624.63K	99,148
Mar 29, 2023	Hankey Don	director, 10 percent owner, officer	Chairman of the Board	J-Other	Buy	37,918	$6.30	$238.88K	37,918
Mar 29, 2023	Hankey Don	director, 10 percent owner, officer	Chairman of the Board	J-Other	Buy	19,297	$6.30	$121.57K	19,297
Mar 29, 2023	Hankey Don	director, 10 percent owner, officer	Chairman of the Board	J-Other	Buy	5,252	$6.30	$33.09K	5,252
Mar 29, 2023	Hankey Don	director, 10 percent owner, officer	Chairman of the Board	J-Other	Sell	33,811	$6.30	$213.01K	-
Mar 29, 2023	Hankey Don	director, 10 percent owner, officer	Chairman of the Board	J-Other	Sell	500,137	-	-	-

The last insider sell of Bone Biologics's stock was made by Gagnon Robert E. on Jan 10 2024, selling - shares at - per share (valued at -). The last insider buy of BBLG was made by Walsh Deina H on Sep 14 2023, buying 8,000 shares at $0.64 per share (worth $5.12K).

Bone Biologics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	6	2	300.00%
Q3 2023	16	-	-
Q1 2023	14	4	350.00%
Q3 2022	6	-	-
Q1 2022	5	-	-
Q4 2021	6	4	150.00%
Q1 2020	2	-	-
Q3 2019	4	-	-
Q2 2019	4	-	-
Q1 2019	3	-	-
Q4 2018	2	-	-
Q3 2018	-	-	-
Q1 2018	5	-	-
Q4 2017	1	-	-
Q3 2017	2	2	100.00%
Q1 2017	2	-	-
Q3 2016	2	1	200.00%
Q2 2016	2	1	200.00%
Q1 2016	5	-	-
Q4 2015	22	9	244.44%

6 total buy trades, and 2 total sell trades (buy/sell ratio of 3.00%) were made by Bone Biologics's insiders, as of Q1 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	-	-
Q3 2023	10	-	-
Q1 2023	-	-	-
Q3 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	-	-	-
Q1 2020	2	-	-
Q3 2019	4	-	-
Q2 2019	4	-	-
Q1 2019	2	-	-
Q4 2018	2	-	-
Q3 2018	-	-	-
Q1 2018	-	-	-
Q4 2017	-	-	-
Q3 2017	-	-	-
Q1 2017	-	-	-
Q3 2016	-	-	-
Q2 2016	-	-	-
Q1 2016	1	-	-
Q4 2015	-	7	-

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Bone Biologics's stocks.

Bone Biologics Peer Ownership

Ticker	Company
TLIS	Talis Biomedical Corporation
RPID	Rapid Micro Biosystems, Inc.
INVO	INVO Bioscience, Inc.
TIVC	Tivic Health Systems, Inc.
NUWE	Nuwellis, Inc.
RSLS	ReShape Lifesciences Inc.
BJDX	Bluejay Diagnostics, Inc.
HSCS	Heart Test Laboratories, Inc.
MOTS	Motus GI Holdings, Inc.
SINT	Sintx Technologies, Inc.
TNON	Tenon Medical, Inc.
NAOV	NanoVibronix, Inc.
VVOS	Vivos Therapeutics, Inc.

BBLG Ownership FAQ

Who Owns Bone Biologics?

Bone Biologics is owned by institutional shareholders (0.06%), insiders (6.07%), and public (93.87%). The largest institutional shareholder of Bone Biologics is UBS GROUP AG (5.10% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of Bone Biologics?

Bone Biologics's major institutional shareholders are UBS GROUP AG, HRT FINANCIAL LP, TOWER RESEARCH CAPITAL LLC (TRC), MFA WEALTH ADVISORS, LLC, and BANK OF AMERICA CORP /DE/. The top five shareholders own together 8.69% of the company's share outstanding.

How many Bone Biologics shareholders are there?

As of Jun 2024, there are 1 institutional shareholders of Bone Biologics.

What percentage of Bone Biologics is owned by UBS GROUP AG?

UBS GROUP AG owns 33.71K shares of Bone Biologics, representing 5.10% of the company's total shares outstanding, valued at $41.12K (as of Jun 2024).

What percentage of Bone Biologics is owned by HRT FINANCIAL LP?

As of Jun 2024, HRT FINANCIAL LP holds 17.52K shares of Bone Biologics (BBLG), compromising 2.65% of the company, valued at $21K.

What percentage of Bone Biologics is owned by TOWER RESEARCH CAPITAL LLC (TRC)?

TOWER RESEARCH CAPITAL LLC (TRC) is the third largest holder of Bone Biologics. The company owns 5.79K of the company's shares outstanding (worth $7.06K).